Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ABBV34 | B3 | BRL | Delayed | |
ABBV | NYSE | USD | Real-time | |
0QCV | London | EUR | Real-time | |
ABBV | CBOE Canada | CAD | Real-time | |
ABBV | Mexico | MXN | Delayed | |
ABBV | BIVA | MXN | Delayed | |
1ABBV | Milan | EUR | Real-time | |
4AB | Frankfurt | EUR | Delayed | |
4AB | TradeGate | EUR | Delayed | |
ABBVm | Buenos Aires | ARS | Delayed | |
ABBV | Vienna | EUR | Real-time | |
ABBV | Lima | USD | Delayed |
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn’s disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; Evolveimmune Therapeutics, Inc.; Genentech, Inc.; and Tentarix Biotherapeutics, LP. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Name | Age | Since | Title |
---|---|---|---|
Robert A. Michael | 54 | 2015 | CEO & Director |
Richard A. Gonzalez | 70 | 2013 | Executive Chairman |
Roxanne S. Austin | 63 | 2013 | Lead Independent Director |
Thomas Craig Freyman | 70 | 2020 | Independent Director |
Rebecca B. Roberts | 71 | 2018 | Independent Director |
Jennifer L. Davis | 52 | 2023 | Independnet Director |
Susan E. Quaggin | 60 | 2023 | Independnet Director |
Robert J. Alpern | 73 | 2013 | Independent Director |
William H. L. Burnside | 72 | 2013 | Independent Director |
Melody Boone Meyer | 67 | 2017 | Independent Director |
Frederick H. Waddell | 70 | 2013 | Independent Director |
Edward Joseph Rapp | 66 | 2013 | Independent Director |
Brett J. Hart | 54 | 2016 | Independent Director |
Glenn F. Tilton | 76 | 2013 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review